1. Home
  2. TDOC vs PVLA Comparison

TDOC vs PVLA Comparison

Compare TDOC & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teladoc Health Inc.

TDOC

Teladoc Health Inc.

HOLD

Current Price

$6.23

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

HOLD

Current Price

$151.21

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TDOC
PVLA
Founded
2002
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
2015
2013

Fundamental Metrics

Financial Performance
Metric
TDOC
PVLA
Price
$6.23
$151.21
Analyst Decision
Buy
Strong Buy
Analyst Count
18
15
Target Price
$7.56
$171.87
AVG Volume (30 Days)
3.1M
160.3K
Earning Date
04-29-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
80.58
52.62
EPS
N/A
N/A
Revenue
$2,406,840,000.00
$42,810,000.00
Revenue This Year
$1.19
N/A
Revenue Next Year
$1.25
$104,350.18
P/E Ratio
N/A
N/A
Revenue Growth
18.41
65.28
52 Week Low
$4.40
$56.55
52 Week High
$9.89
$161.38

Technical Indicators

Market Signals
Indicator
TDOC
PVLA
Relative Strength Index (RSI) 41.33 50.36
Support Level $6.18 $145.91
Resistance Level $6.24 $151.18
Average True Range (ATR) 0.24 5.61
MACD 0.06 -0.27
Stochastic Oscillator 29.45 51.04

Price Performance

Historical Comparison
TDOC
PVLA

About TDOC Teladoc Health Inc.

Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including counseling and therapy delivered through digital platforms. It generates the majority of its revenue from the Integrated Care segment.

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. Its product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations and cutaneous venous malformations. It operates in single segment.

Share on Social Networks: